カテゴリ： IMARC, 世界, 医療/バイオ

心臓バイオマーカーのグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）

■ 英語タイトル：Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

調査会社IMARC社が発行したリサーチレポート（データ管理コード：IMARC23FB0193）■ 発行会社/調査会社：IMARC
■ 商品コード：IMARC23FB0193
■ 発行日：2023年2月1日
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：112
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥449,850見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥599,850見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥749,850見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※IMARC社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[心臓バイオマーカーのグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

IMARC社の市場調査書では、2022年に98億ドルであった世界の心臓バイオマーカー市場規模が2028年に162億ドルへ増加し、2023年から2028年の間にCAGR 8.42％拡大すると推測されています。当書では、心臓バイオマーカーの世界市場を調査対象とし、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（トロポニン（T・I）、心筋クレアチンキナーゼ（CK-MB）、脳性ナトリウム利尿ペプチド（BNP）・NT-proBNP、虚血変性アルブミン（IMA）、その他）分析、検査部位別（研究所検査、ポイントオブケア検査）分析、用途別（心筋梗塞、うっ血性心不全、急性冠症候群、動脈硬化症、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中東・アフリカ、中南米）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競合状況などを整理しました。並びに、当書に掲載されている企業情報には、Abbott Laboratories、Alere Inc.、Beckman Coulter、Becton、Dickinson And Co.、Biomerieux、Bio-Rad Laboratories、Randox Laboratories、Roche Diagnostics Corporation、Siemens Healthcare and Thermo Fisher Scientific.などが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界の心臓バイオマーカー市場規模：種類別
- トロポニン（T・I）の市場規模
- 心筋クレアチンキナーゼ（CK-MB）の市場規模
- 脳性ナトリウム利尿ペプチド（BNP）・NT-proBNPの市場規模
- その他心臓バイオマーカーの市場規模
・世界の心臓バイオマーカー市場規模：検査部位別
- 研究所検査における市場規模
- ポイントオブケア検査における市場規模
・世界の心臓バイオマーカー市場規模：用途別
- 心筋梗塞における市場規模
- うっ血性心不全における市場規模
- 急性冠症候群における市場規模
- 動脈硬化症における市場規模
- その他用途における市場規模
・世界の心臓バイオマーカー市場規模：地域別
- 北米の心臓バイオマーカー市場規模
- アジア太平洋の心臓バイオマーカー市場規模
- ヨーロッパの心臓バイオマーカー市場規模
- 中東・アフリカの心臓バイオマーカー市場規模
- 中南米の心臓バイオマーカー市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競合状況

The global cardiac biomarkers market size reached US$ 9.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.2 Billion by 2028, exhibiting a growth rate (CAGR) of 8.42% during 2023-2028.

Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac troponins, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin. Measurement and testing of these markers can help in diagnosing heart conditions like cardiac ischemia and acute coronary syndrome (ACS). At present, the triage and diagnostic systems used for determining the risk of these conditions are based on electrocardiograms (ECGs) and clinical history. However, these systems are insufficient and can lead to misdiagnosis or delay in treatment. As cardiac marker testing offers higher accuracy and can identify the conditions in the early stages of presentation, they are gaining traction across the globe. These markers can also help in monitoring the prognosis of these condition with greater accuracy and providing the most effective treatment to the patients.

Global Cardiac Biomarkers Market Drivers:
Over the past few years, there has been a rise in the number of patients suffering from ACS which has created a demand for cardiac marker testing at a global level. Other than this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. In addition, there are numerous private and public organizations which are investing in R&D activities to develop advanced technologies in the field of cardiac biomarkers. For instance, blood tests for high-sensitivity cardiac troponin I have been demonstrated to identify patients who are at a higher risk of a second heart attack. Moreover, high accuracy and rapid results offered by biomarker testing, coupled with the availability of affordable cardiac point-of-care testing, are some of the other factors which are contributing to the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiac biomarkers market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on type, location of testing, and application.

Breakup by Type:

Troponins (T and I)
Myocardial Muscle Creatine Kinase (CK-MB)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia Modified Albumin (IMA)
Others

Based on the type, the market has been segmented into troponins (T and I), myocardial muscle creatine kinase (CK-MB), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA) and others.

Breakup by Location of Testing:

Laboratory Testing
Point of Care Testing

Based on the location of testing, the market has been segmented into laboratory testing and point of care testing. Laboratory testing currently accounts for a larger share.

Breakup by Application:

Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others

Based on the application, the market has been segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Myocardial infarction currently accounts for the highest share.

Regional Insights:

North America
Asia Pacific
Europe
Middle East and Africa
Latin America

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for majority of the global share.

Competitive Landscape:
The report has also analyzed the competitive landscape of the market with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.

Key Questions Answered in This Report
1. What was the size of the global cardiac biomarkers market in 2022?
2. What is the expected growth rate of the global cardiac biomarkers market during 2023- 2028?
3. What are the key factors driving the global cardiac biomarkers market?
4. What has been the impact of COVID-19 on the global cardiac biomarkers market?
5. What is the breakup of the global cardiac biomarkers market based on the location of testing?
6. What is the breakup of the global cardiac biomarkers market based on the application?
7. What are the key regions in the global cardiac biomarkers market?
8. Who are the key companies/players in the global cardiac biomarkers market?

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cardiac Biomarkers Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Type
5.5 Market Breakup by Location of Testing
5.6 Market Breakup by Application
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Type
6.1 Troponins (T and I)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Myocardial Muscle Creatine Kinase (CK-MB)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Myoglobin
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Ischemia Modified Albumin (IMA)
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Location of Testing
7.1 Laboratory Testing
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Point of Care Testing
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Myocardial Infarction
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Congestive Heart Failure
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Acute Coronary Syndrome
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Atherosclerosis
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Asia Pacific
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Europe
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast
10 Global Cardiac Biomarkers Industry: SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Global Cardiac Biomarkers Industry: Value Chain Analysis
12 Global Cardiac Biomarkers Industry: Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Global Cardiac Biomarkers Industry: Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.2 Alere Inc.
14.3.3 Beckman Coulter
14.3.4 Becton, Dickinson And Co.
14.3.5 Biomerieux
14.3.6 Bio-Rad Laboratories
14.3.7 Randox Laboratories
14.3.8 Roche Diagnostics Corporation
14.3.9 Siemens Healthcare
14.3.10 Thermo Fisher Scientific

Figure 1: Global: Cardiac Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Cardiac Biomarkers Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cardiac Biomarkers Market: Breakup by Type (in %), 2022
Figure 4: Global: Cardiac Biomarkers Market: Breakup by Location of Testing (in %), 2022
Figure 5: Global: Cardiac Biomarkers Market: Breakup by Application (in %), 2022
Figure 6: Global: Cardiac Biomarkers Market: Breakup by Region (in %), 2022
Figure 7: Global: Cardiac Biomarkers Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Cardiac Biomarkers Industry: SWOT Analysis
Figure 9: Global: Cardiac Biomarkers Industry: Value Chain Analysis
Figure 10: Global: Cardiac Biomarkers Industry: Porter’s Five Forces Analysis
Figure 11: Global: Cardiac Biomarkers (Troponins) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Cardiac Biomarkers (Troponins) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Cardiac Biomarkers (Myoglobin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Cardiac Biomarkers (Myoglobin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Cardiac Biomarkers (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Cardiac Biomarkers (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Cardiac Biomarkers (Laboratory Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Cardiac Biomarkers (Laboratory Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Cardiac Biomarkers (Point of Care Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Cardiac Biomarkers (Point of Care Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Cardiac Biomarkers (Myocardial Infarction) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Cardiac Biomarkers (Myocardial Infarction) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Cardiac Biomarkers (Congestive Heart Failure) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Cardiac Biomarkers (Congestive Heart Failure) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Cardiac Biomarkers (Atherosclerosis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Cardiac Biomarkers (Atherosclerosis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Cardiac Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Cardiac Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: North America: Cardiac Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: North America: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Asia Pacific: Cardiac Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Asia Pacific: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Europe: Cardiac Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Europe: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Middle East and Africa: Cardiac Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Middle East and Africa: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Latin America: Cardiac Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Latin America: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028

Table 1: Global: Cardiac Biomarkers Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cardiac Biomarkers Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Cardiac Biomarkers Market Forecast: Breakup by Location of Testing (in Million US$), 2023-2028
Table 4: Global: Cardiac Biomarkers Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Cardiac Biomarkers Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Cardiac Biomarkers Market Structure
Table 7: Global: Cardiac Biomarkers Market: Key Players

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • バイオマーカーのグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
  • 臨床診断のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
  • コンパニオンアニマルヘルスのグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
  • 不妊検査のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
  • 心血管インプラントのグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IMARC23FB0193 )"心臓バイオマーカーのグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）" (英文：Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)はIMARC社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。